Fact CheckerSign in

NCT07314879Completed

Impact of Interventional Revascularization on the Physiological Assessment of Bystander Coronary Lesions by FFR

Impact of Interventional Revascularization on the Physiological Assessment of Bystander Coronary Lesions by FFR (ABC-FFR)

Source: ClinicalTrials.gov · Last updated 2 Jan 2026

Brief summary (registry, in English)

The ABC-FFR trial examines the understudied hemodynamic interaction between parallel coronary stenoses, as the physiological impact of treating one lesion on the pressure indices of lesions in separate parallel branches is not yet fully understood. This prospective, multicenter study enrolls patients scheduled for percutaneous coronary intervention (PCI) of a designated index lesion who also present with a concurrent remote stenosis in a parallel coronary artery. It evaluates potential changes in fractional flow reserve (FFR) and non-hyperemic pressure ratio (NHPR) measurements within the remote lesion both before and after the index lesion is revascularized.

Status (registry)
Completed
Study type
Observational
Enrollment
160 (actual)
First submitted
18 Dec 2025
Start date
Jun 2020
Primary completion date
Jun 2025
Lead sponsor
Friedrich-Alexander-Universität Erlangen-Nürnberg
NCT number
NCT07314879

What you commit to

  • Study type: Observational
  • Participants enrolled: 160
  • From Jun 2020 to the primary completion date, Jun 2025
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • ST-elevation myocardial infarction
  • Non-ST-elevation myocardial infarction with immediate invasive strategy recommended by current ESC guidelines (e.g. due to hemodynamic instability, cardiogenic shock, acute heart failure presumed secondary to ongoing myocardial ischemia, recurrent or ongoing chest pain refractory to medical treatment, or life-threatening arrhythmias or cardiac arrest after presentation)

Other

  • Acute totally occluded coronary artery
  • Unsuitability for intracoronary measurement of FFR (e.g. due to contraindications for the administration of adenosine)

Who the study is looking for

  • Age ≥ 18 years
  • Scheduled percutaneous coronary intervention for at least one coronary lesion (as indicated by evidence of myocardial ischemia on non-invasive stress imaging, an angiographic stenosis severity \>90% diameter stenosis, or an hemodynamically significant intracoronary pressure measurement)
  • Additional stenosis of ≥ 30% diameter stenosis in a parallel coronary artery anatomically suitable for wire-based intracoronary pressure assessment

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Steigerwaldklinik Burgebrach
Coordinator of this site? Confirm its status
BurgebrachGermanyUnknown status
Department of Medicine 1 - Cardiology, Nephrology, Intensive Care and Rhythmology, St. Johannes Hospital Dortmund
Coordinator of this site? Confirm its status
DortmundGermanyUnknown status
Deparment of Medicine 2 - Cardiology and Angiology, Friedrich-Alexander-Universität Erlangen-Nürnberg
Coordinator of this site? Confirm its status
ErlangenGermanyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.